Connectome and molecular pharmacological differences in the dopaminergic system in restless legs syndrome (RLS): plastic changes and neuroadaptations that may contribute to augmentation-Reference-Cited by-同舟云学术

Connectome and molecular pharmacological differences in the dopaminergic system in restless legs syndrome (RLS): plastic changes and neuroadaptations that may contribute to augmentation

Published:2017-03 Issue: Volume:31 Page:71-77
ISSN:1389-9457
Container-title:Sleep Medicine
language:en
Short-container-title:Sleep Medicine

Author:

Earley Christopher J.,Uhl George R.,Clemens Stefan,Ferré Sergi

Funder

National Institute on Drug Abuse

Publisher

Elsevier BV

Subject

General Medicine

Reference96 articles.

1. An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder;Hening;Sleep,2004

2. The long-term treatment of restless legs syndrome/Willis–Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group;Garcia-Borreguero;Sleep Med,2013

3. Selective D1- and D2-dopamine receptor blockade both induces akathisia in humans–a PET study with [11C]SCH 23390 and [11C]raclopride;Farde;Psychopharmacology (Berl),1992

4. Pharmacokinetic and concentration-effect studies with intravenous metoclopramide;Bateman;Br J Clin Pharmacol,1978

5. Opioid and dopamine antagonist drug challenges in untreated restless legs syndrome patients;Winkelmann;Sleep Med,2001

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the adenosinergic system in restless legs syndrome: A pilot, “proof-of-concept” placebo-controlled TMS-based protocol;PLOS ONE;2024-05-10

2. Identification of MAN1A2 as Potential Drug Target for Restless Legs Syndrome: A Comprehensive Mendelian Randomization Study;2024

3. Restless Legs Syndrome and Nocturnal Movement Disorders;Reference Module in Neuroscience and Biobehavioral Psychology;2024

4. Restless legs syndrome: From clinic to personalized medicine;Revue Neurologique;2023-10

5. Effectiveness of exercise and pramipexole in the treatment of restless leg syndrome: Implications on the dopaminergic system and PTPRD;Sleep Medicine;2023-10